IT Compliance for Medical Device Companies

Medical device companies operate under a regulatory framework that treats IT infrastructure as inseparable from product quality and patient safety. The FDA does not view your servers, software systems, and data management practices as back-office concerns. It considers them integral to whether your devices are safe, effective, and manufactured under adequate controls. A failed IT audit can delay a 510(k) clearance, trigger a warning letter, or halt production until deficiencies are resolved.

The challenge for medical device firms, particularly small and mid-size manufacturers in Southern California’s growing medtech corridor, is that the regulatory requirements span multiple frameworks simultaneously. FDA Quality System Regulation, electronic records rules, cybersecurity expectations, and often HIPAA obligations all apply to the same IT environment. Understanding where these requirements overlap and how to satisfy them efficiently is the difference between a compliance program that supports your business and one that consumes it.

21 CFR Part 11: Electronic Records and Electronic Signatures

21 CFR Part 11 establishes the FDA’s requirements for electronic records and electronic signatures. Any medical device company that uses electronic systems to create, modify, maintain, archive, retrieve, or transmit records required by FDA regulations must comply with Part 11. In practice this applies to nearly every modern manufacturer, since quality records, design history files, device master records, complaint files, and CAPA documentation are almost universally managed electronically.

Part 11 compliance requires your systems to maintain complete audit trails that record who made changes, what was changed, when the change occurred, and the reason for the change. These audit trails must be computer-generated and cannot be modified by the users whose actions they record. The practical implication is that any software handling regulated records, whether it is a commercial quality management system, an ERP platform, or even structured spreadsheets, must produce tamper-evident logs of every action.

Electronic signatures under Part 11 must be uniquely linked to a single individual and must include controls that prevent anyone from using another person’s credentials. Systems must require signature manifestations that include the printed name of the signer, the date and time of signing, and the meaning associated with the signature such as approval, review, or verification. Biometric signatures carry different requirements than non-biometric ones, but the core principle is the same: the FDA must be able to trust that the person identified as signing a record is in fact the person who signed it.

Companies frequently underestimate Part 11 by assuming it only applies to their QMS software. It applies to any electronic system that generates records the FDA can request during an inspection. If your engineering team tracks design changes in a project management tool, if your production team logs environmental monitoring data in a database, or if your quality team reviews complaints through an electronic workflow, those systems fall under Part 11 scrutiny.

21 CFR Part 820: Quality System Regulation and IT

The Quality System Regulation under 21 CFR Part 820 governs the methods, facilities, and controls used in the design, manufacture, packaging, labeling, storage, installation, and servicing of medical devices. While Part 820 addresses the entire quality system, several provisions carry direct implications for IT infrastructure.

Document controls under Section 820.40 require that all documents, including electronic ones, be reviewed and approved before use, distributed to appropriate locations, and removed from use when obsolete. For IT departments this means implementing version control systems that prevent unauthorized modifications, ensure only current documents are accessible, and maintain historical records of all revisions. A production operator referencing an outdated work instruction because the file server was not updated is exactly the kind of failure that FDA investigators document during inspections.

Device history records under Section 820.184 must include manufacturing dates, quantities, acceptance records, labeling, and identification of equipment used. When these records are generated or stored electronically, the IT systems responsible for them must meet both Part 820 documentation requirements and Part 11 electronic records requirements simultaneously. The systems must be validated, access-controlled, and backed up in ways that ensure record integrity and availability throughout the required retention period.

Software used as part of your quality system, often called computer software assurance in current FDA terminology, must be validated for its intended use. This includes commercial off-the-shelf software configured for quality-critical purposes. The FDA’s guidance on Computer Software Assurance provides a risk-based framework for determining the appropriate level of validation effort, but the core requirement remains: you must be able to demonstrate that your quality system software performs reliably and as intended.

FDA Cybersecurity Requirements

The FDA has progressively strengthened its expectations for cybersecurity in medical devices and the manufacturing environments that produce them. The Consolidated Appropriations Act of 2023 amended the Federal Food, Drug, and Cosmetic Act to require cybersecurity information in premarket submissions for cyber devices. This means cybersecurity is no longer guidance; for devices that connect to the internet or contain software, it is a statutory requirement.

For manufacturers, these requirements extend beyond the device itself to the infrastructure used to develop and manufacture it. An attacker who compromises your development environment could introduce malicious code into device firmware. An attacker who penetrates your manufacturing network could alter production parameters. The FDA expects manufacturers to protect not only the devices they ship but the systems they use to design, build, and test those devices.

Practical cybersecurity measures for medical device manufacturing environments include network segmentation that isolates production systems from corporate IT, endpoint protection on all engineering workstations, secure software development practices including code signing and integrity verification, vulnerability management programs that track and remediate known weaknesses, and access controls that enforce the principle of least privilege across development and manufacturing systems.

The FDA also expects manufacturers to have a plan for monitoring, identifying, and addressing post-market cybersecurity vulnerabilities in their devices. This requires IT infrastructure capable of receiving and processing vulnerability reports, tracking affected device populations, validating and distributing patches, and maintaining communication channels with healthcare facilities that use your products.

HIPAA Overlap for Connected Devices

Medical device companies whose products create, receive, maintain, or transmit protected health information face HIPAA obligations in addition to FDA requirements. A patient monitoring device that records vital signs, a diagnostic instrument that generates test results linked to patient identifiers, or a connected therapeutic device that transmits treatment data all handle PHI and trigger HIPAA compliance requirements.

The overlap creates dual obligations for IT infrastructure. Systems must satisfy both FDA data integrity requirements and HIPAA privacy and security standards. In practice the technical controls are complementary: encryption, access controls, audit logging, and incident response procedures serve both frameworks. The documentation requirements differ, however, and organizations must maintain compliance artifacts that address each framework’s specific expectations.

Business associate agreements become particularly important when medical device companies provide cloud-connected devices to healthcare organizations. If your device transmits patient data to your servers for analysis, storage, or monitoring, you are likely a business associate under HIPAA and must comply with the Security Rule, including conducting risk assessments, implementing administrative and technical safeguards, and reporting breaches within required timeframes.

Computer System Validation

Validation of computerized systems is a foundational requirement that runs through every aspect of medical device IT compliance. The FDA expects that any computer system used in quality-critical processes has been validated to perform its intended function reliably and consistently. This applies to quality management software, enterprise resource planning systems, laboratory information management systems, manufacturing execution systems, document management platforms, and any custom-developed tools used in regulated processes.

A validation program should follow a lifecycle approach: define user requirements, create functional and design specifications, execute installation, operational, and performance qualification protocols, and maintain the validated state through change control procedures. Each validation must be documented in a validation package that an FDA investigator can review to understand what was tested, what the acceptance criteria were, whether the system met those criteria, and who approved the validation.

Change control is where many organizations struggle. A validated system that receives an update, configuration change, or integration with a new platform must be evaluated for revalidation. The scope of revalidation depends on the nature and risk of the change, but the decision process itself must be documented. Skipping change control for software updates is one of the most common observations FDA investigators make during inspections of medical device manufacturers.

Document Control and Records Management

Effective document control is the backbone of regulatory compliance for medical device companies, and IT systems are the mechanism through which document control operates at scale. Your document management system must enforce approval workflows that prevent unapproved documents from reaching production, maintain revision histories that allow reconstruction of any document’s evolution, control distribution so that only current versions are available at points of use, and archive obsolete versions in a retrievable but clearly identified state.

Records retention requirements vary by record type but generally extend for the expected lifetime of the device plus additional periods specified by regulation. Design history files, device master records, device history records, complaint files, and CAPA records all carry specific retention requirements. Your IT infrastructure must support these retention periods with storage solutions that maintain data integrity, remain accessible through technology changes, and are protected against loss through backup and disaster recovery procedures.

Migration planning deserves particular attention. Medical device records may need to remain accessible for decades. Systems and formats change. A records management strategy that accounts for technology transitions, data migration validation, and format longevity prevents the situation where regulated records exist on media or in formats that can no longer be read when an investigator requests them.

Supplier and Vendor IT Controls

Medical device companies are responsible for ensuring that suppliers and vendors who provide IT services or host regulated data meet applicable compliance requirements. When your quality management system runs in a vendor’s cloud, when your design files are stored on a third-party platform, or when an IT service provider manages your network infrastructure, the regulatory responsibility for data integrity and security remains with you.

Supplier qualification for IT vendors should evaluate their security certifications, regulatory experience, validation documentation, data handling practices, backup and disaster recovery capabilities, and incident response procedures. SOC 2 Type II reports provide useful evidence of a vendor’s security controls, but they are not sufficient by themselves. You must also evaluate whether the vendor understands FDA-regulated environments and can support your specific compliance obligations.

Contracts with IT vendors should include provisions for audit rights, data ownership, breach notification timelines, data return and destruction upon termination, and support for regulatory inspections. The FDA can and does request access to records held by third parties, and your contracts must ensure you can produce those records when required.

Building an Integrated Compliance Program

The most effective approach to medical device IT compliance treats FDA, HIPAA, and cybersecurity requirements as components of a single integrated program rather than separate initiatives managed by different teams. The technical controls overlap significantly. Audit trails serve Part 11, HIPAA, and cybersecurity requirements simultaneously. Encryption protects both PHI and regulated quality records. Access controls satisfy every framework on the list.

Start with a comprehensive risk assessment that maps your IT environment against all applicable requirements. Identify the systems that handle regulated data, evaluate the controls currently in place, document the gaps, and prioritize remediation based on risk to patient safety and regulatory exposure. This assessment becomes the foundation for your compliance program and the evidence that you are actively managing your obligations.

Maintain a compliance calendar that schedules recurring activities: system validation reviews, access audits, backup testing, security assessments, training refreshers, and document control reviews. Regulatory compliance is not a project with a completion date. It is an operational discipline that requires continuous attention and periodic demonstration of effectiveness.

Medical device IT compliance demands specialized expertise in both regulatory requirements and technical implementation. Contact We Solve Problems to build an IT environment that satisfies FDA investigators, protects patient data, and keeps your devices moving through the regulatory pipeline.